<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serum levels of complement components Clq, C4, C3, and Properdin factor B, from the classical and alternative pathways of complement activation, have been estimated in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>C3, factor B, and to some extent C4 concentrations <z:hpo ids='HP_0000001'>all</z:hpo> increased when the disease was active </plain></SENT>
<SENT sid="2" pm="."><plain>In remission the levels of these components did not differ from hospital control patients </plain></SENT>
<SENT sid="3" pm="."><plain>There was no evidence for the preferential consumption of the proteins of either pathway of activation, even in those patients with evidence of circulating immune complexes </plain></SENT>
</text></document>